Intelligent Bio Solutions Reports Q1 Revenue of $1.39 Million and Improved Gross Margins
Intelligent Bio Solutions (INBS) has released its first-quarter financial results, reporting a GAAP EPS of -$0.86 on revenue of $1.39 million. Despite the net loss, the company demonstrated significant operational improvement with gross profit rising 46% year-over-year to $758,004. Gross profit margins also saw an expansion, increasing to 54.5% from 46.6% in the prior year period. The company's liquidity position strengthened significantly, with cash and cash equivalents rising to $5.93 million as of September 30, 2026, up from $3.99 million at the end of June.
Tickers: $INBS
Topics: cash position earnings report gross margin expansion revenue growth
Read the full article at Seeking Alpha
Part of the story The Adecco Group Reports Q3 2026 Growth and Margin Expansion (9 articles)